12 - 14 November, 2019 | Hilton Munich City, Munich, Germany

Data Analytics Content

2019 Agenda | Data Analytics for Pharma Development

Here you can find the 2019 Agenda for Data Analytics for Pharma Development Conference. Discover the confirmed speakers and their presentations by clicking here

Spotlight Content

Infographic:Latest Industry Trends 2019

Ahead of the 5th Annual Data Analytics for Pharma Development Forum 2019, taking place on 12-14 November in Munich, we conducted an industry wide survey. In this infographic you will learn about the biggest challenges that are facing those using data analytics in their drug development, the strengths of using...

Interview: The Impact of Data on Drug Development

Ahead of the 5th Annual Data Analytics for Pharma Development Forum (Munich, 12-14thNovember 2019), we asked Nigel Hughes, Scientific Director at Janssen, to have a chat with us about the role of data analytics in the pharmaceutical industry and the impact AI & Machine Learning, RWD/RWE, GDPR and clinical trials...

Artificial Intelligence set to Revolutionise Drug Discovery

Artificial Intelligence, Machine Learning and other technologies are expected to make the discovery and development of new pharmaceuticals quicker, cheaper and more effective. Download this article to hear experts insights from Leonardo Rodrigues, Senior Director, AI & Machine Learning at BERG Heath about how these tools will revolutionise drug development...

Infographic: Harnessing the power of data

While most industries are already benefiting from better use of dataanalytics, Pharma has been slow to innovate their business mode and adopt new technologies. Pharma R&D is stalling, there is a cap onproductivity and companies need to leverage data insights to move forwards. With insights from Larry Pickett, CEO, RxDataScience,...

Additional Content Download

The Power of Big Data Anaytics in Pharma [Infographic]

In this infographic experts provide insight on the opportunities that exist in big data analytics for Pharma and how pharma firms can capitalise on cracking open their data silos.

Big Data in Life Sciences - Beyond the Buzz

Big data has moved beyond the big hype. The data landscape in life sciences is changing rapidly, advancing technologies, pre-competitive data sharing and huge growth of structured and unstructured data volumes available to organisations are driving big data breakthroughs. Life science companies are looking for new ways to leverage big...

Drowning in Data, but Starving for Knowledge? How to Define Big Data for Healthcare

Thomas R. Ortiz, is the Chief Medical Officer at Reliance Medical Group, LLC and operates the Primary Care Medical Practices in five counties within New Jersey. In this interview, Ortiz says his business would do better with more organised data streams, which would improve overall outcomes and costs. Find out...

Creating An Efficiency Value of $1 Million With Data Analytics

Big Data in healthcare delivery is really an illusion, according to Daniel Morreale, the Vice President and Chief Information Officer at Kingsbrook Jewish Medical Center. Other than large, academic medical centers, or medical giants such as Quest or Kaiser Permanente, a majority of big hospitals are doing very little with...

Real World Data: Turning Volume in Value

Real World Data can benefit multiple stakeholders within the value chain in order to support the commercialisation of strategies and provide insightful analysis for differentiation, to assist with regulatory submissions and to influence the market access strategies. However, it is not without its limitations and there a number of issues...

Does Big Data in Pharma = Big Money?

As of now, big data is not used as often and as well as it should be in the Pharmaceutical Industry.   Slowly the Industry is adopting data and analytics to improve itself. Data usage could lead to accelerated drug discovery, better help patients and predict emergency rush hours.  To keep...

How to Create a Competitive Advantage with Big Data Analytics in Pharma

Nigel Hughes, Director Integrative Healthcare Informatics, Janssen R&D, takes a closer look at how access to external data is critical in today’s world and the ways data accessibility can provide pharmaceutical companies with a competitive advantage. With large scale initiatives coming into practice, such as the European Medical Information Framework...

It is a good time to be a data scientist in the pharmaceutical industry

We caught up with Nigel Hughes, Scientific Director at Janssen, to explore the role of data analytics in the pharmaceutical industry, the challenges for those already working in data teams and the future of predictive analytics.

Best in Class Case Study with Allan Jordan

Allan Jordan strongly believes that while big data is important and can change pharma, it should not just be gathered without reason. There needs to be a purpose, and purpose is the main thing driving his latest project.  The project in question is focused on exploiting genome sequencing efforts to...

Top 5 tips to incorporate data visualisation into a successful business strategy

The biggest challenge life science companies now face is to learn how to use data, source of an enormous amount of information, and step out of the silos. Ahead of the third annual Data Analytics for Pharma Development, PharmaIQ had an exclusive interview Marie Montoya, CEO and Founder or M...